Monopar Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Monopar Therapeutics Inc (Monopar) is a biopharmaceutical company that develops drugs and drug combinations to improve clinical outcomes for cancer patients. The companys pipeline product includes huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. Its huATN-658 targets the urokinase plasminogen activator receptor. Monopar builds development pipeline through the licensing or acquisition of orphan oncology therapeutics at the preclinical through advanced clinical development stage. The companys lead drug product candidate enters into clinical development through collaboration with research center in the UK. Monopar is headquartered in Wilmette, Illinois, the US.

Monopar Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Monopar Therapeutics Acquires GPX-150 from Gem Pharma 10
Venture Financing 11
Monopar Therapeutics Raises USD9.7 Million in Venture Financing 11
Monopar Therapeutics to Raise USD4.5 Million in Venture Financing 12
Monopar Therapeutics to Raise USD3 Million Financing 13
Monopar Therapeutics Raises USD2.1 Million Financing 14
Partnerships 15
Monopar Therapeutics Enters into Agreement with Cancer Research UK and Cancer Research Technology 15
Licensing Agreements 16
Monopar Therapeutics Enters into Licensing Agreement with Onxeo 16
Monopar Therapeutics Inc - Key Competitors 17
Monopar Therapeutics Inc - Key Employees 18
Monopar Therapeutics Inc - Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Monopar Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Monopar Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Monopar Therapeutics Acquires GPX-150 from Gem Pharma 10
Monopar Therapeutics Raises USD9.7 Million in Venture Financing 11
Monopar Therapeutics to Raise USD4.5 Million in Venture Financing 12
Monopar Therapeutics to Raise USD3 Million Financing 13
Monopar Therapeutics Raises USD2.1 Million Financing 14
Monopar Therapeutics Enters into Agreement with Cancer Research UK and Cancer Research Technology 15
Monopar Therapeutics Enters into Licensing Agreement with Onxeo 16
Monopar Therapeutics Inc, Key Competitors 17
Monopar Therapeutics Inc, Key Employees 18

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Monopar Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Monopar Therapeutics Inc (Monopar) is a biopharmaceutical company that develops drugs and drug combinations to improve clinical outcomes for cancer patients. The companys pipeline product includes huATN-658, a humanized monoclonal

USD 250 View Report

Monopar Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The companys pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers

USD 250 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

USD 750 View Report

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available